Paul Hartmann AGSTU:PHH2 +0.49%61 FCF Margin % is 11.26% as of Dec. 2025, which is 251% above its 10-year median of 3.21. GuruFocus rates STU:PHH2 with a GF Score™ of 61/100 and a GF Value™ of €229.60 (Fairly Valued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Paul Hartmann AG ranks better than 65.28% on this metric.
The historical rank and industry rank for Paul Hartmann AG's FCF Margin % or its related term are showing as below:
STU:PHH2'
s FCF Margin % Range Over the Past 10 Years
Min: -5.15 Med: 3.21 Max: 7.95
Current: 6.32
During the past 13 years, the highest FCF Margin % of Paul Hartmann AG was 7.95%. The lowest was -5.15%. And the median was 3.21%.
STU:PHH2's FCF Margin % is ranked better than 65.28% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs STU:PHH2: 6.32
Paul Hartmann AG FCF Margin % Related Terms
Paul Hartmann AG FCF Margin % Historical Data
* Premium members only.
The historical data trend for Paul Hartmann AG's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:PHH2 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (STU:PHH2) has a FCF Margin % of 11.26% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Paul Hartmann AG and its competitors. This is 251% above median its historical median of 3.21. According to the industry distribution chart, Paul Hartmann AG ranks #283 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 34.7%.
Is Paul Hartmann AG's FCF Margin % too high?
Paul Hartmann AG's current FCF Margin % of 11.26% is 251% above median its 10-year median of 3.21. Based on the distribution chart, Paul Hartmann AG ranks #283 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Paul Hartmann AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Paul Hartmann AG ranks #283 out of 815 companies for FCF Margin %. This puts Paul Hartmann AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Paul Hartmann AG and its competitors. Paul Hartmann AG's current FCF Margin % is 11.26%, which is 251% above median its own 10-year median of 3.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (STU:PHH2) is currently considered Fairly Valued. The stock's GF Value™ is €229.60, compared to a current price of €205.00 — trading 10.7% below its estimated fair value. The current FCF Margin % is 11.26%, which is 251% above median its 10-year median of 3.21. Paul Hartmann AG's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Paul Hartmann AG (STU:PHH2), the current FCF Margin % is 11.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paul Hartmann AG (STU:PHH2) Overvalued in 2026?
Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued.
The current stock price of €205.00 is trading 10.7% below its estimated GF Value™ of €229.60.
GuruFocus considers Paul Hartmann AG to be Fairly Valued.
Key valuation signals for STU:PHH2:
FCF Margin %: 11.26% (251% above median its 10-year median of 3.21)
GF Value™: €229.60 vs. price of €205.00 (10.7% below fair value)
No single metric tells the full story. See the STU:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
61GF Score
Get the complete analysis for STU:PHH2
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:PHH2 has been successfully added to your 
